Evolution of the murine gut resistome following broad-spectrum antibiotic treatment.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
28 04 2022
Historique:
received: 01 02 2021
accepted: 06 04 2022
entrez: 28 4 2022
pubmed: 29 4 2022
medline: 3 5 2022
Statut: epublish

Résumé

The emergence and spread of antimicrobial resistance (AMR) represent an ever-growing healthcare challenge worldwide. Nevertheless, the mechanisms and timescales shaping this resistome remain elusive. Using an antibiotic cocktail administered to a murine model along with a longitudinal sampling strategy, we identify the mechanisms by which gut commensals acquire antimicrobial resistance genes (ARGs) after a single antibiotic course. While most of the resident bacterial populations are depleted due to the treatment, Akkermansia muciniphila and members of the Enterobacteriaceae, Enterococcaceae, and Lactobacillaceae families acquire resistance and remain recalcitrant. We identify specific genes conferring resistance against the antibiotics in the corresponding metagenome-assembled genomes (MAGs) and trace their origins within each genome. Here we show that, while mobile genetic elements (MGEs), including bacteriophages and plasmids, contribute to the spread of ARGs, integrons represent key factors mediating AMR in the antibiotic-treated mice. Our findings suggest that a single course of antibiotics alone may act as the selective sweep driving ARG acquisition and incidence in gut commensals over a single mammalian lifespan.

Identifiants

pubmed: 35484157
doi: 10.1038/s41467-022-29919-9
pii: 10.1038/s41467-022-29919-9
pmc: PMC9051133
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2296

Informations de copyright

© 2022. The Author(s).

Références

Davies, J. & Davies, D. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 74, 417–433 (2010).
pubmed: 20805405 pmcid: 2937522 doi: 10.1128/MMBR.00016-10
Carpenter, K. L., Breckler, F. D. & Gray, B. W. Role of mechanical bowel preparation and perioperative antibiotics in pediatric pull-through procedures. J. Surg. Res. 241, 222–227 (2019).
pubmed: 31029932 doi: 10.1016/j.jss.2019.03.051
Hawn, M. T., Itani, K. M., Gray, S. H. & Vick, C. C. Association of timely administration of prophylactic antibiotics for major surgical procedures and surgical site infection. J. Am. Coll. Surg. 206, 814–99 (2008).
Adamu, B., Abdu, A. & Abba, A. A. Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis. Cochrane Database Syst. Rev. 2014, CD008597 (2014).
He, Y. et al. Antibiotic resistance genes from livestock waste: occurrence, dissemination, and treatment. npj Clean. Water 3, 1–11 (2020).
doi: 10.1038/s41545-020-0051-0
Saust, L. T., Monrad, R. N., Hansen, M. P., Arpi, M. & Bjerrum, L. Quality assessment of diagnosis and antibiotic treatment of infectious diseases in primary care: a systematic review of quality indicators. Scand. J. Prim. Health Care 34, 258 (2016).
pubmed: 27450462 pmcid: 5036015 doi: 10.1080/02813432.2016.1207143
Kliegman, R. & Nelson, W. E. Nelson Textbook of Pediatrics. 903–903.e23 (Elsevier/Saunders, Philadelphia, PA, 2011).
Zackular, J. P., Baxter, N. T., Iverson, K. D. & Sadler, W. D. The gut microbiome modulates colon tumorigenesis. MBio 4, e00692–13 (2013).
Candon, S. et al. Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes. PLoS One 10, e0125448 (2015).
pubmed: 25970503 pmcid: 4430542 doi: 10.1371/journal.pone.0125448
Korte, S. W., Dorfmeyer, R. A., Franklin, C. L. & Ericsson, A. C. Acute and long-term effects of antibiotics commonly used in laboratory animal medicine on the fecal microbiota. Vet. Res. 51, 116 (2020).
pubmed: 32928304 pmcid: 7489021 doi: 10.1186/s13567-020-00839-0
Franklin, C. L. & Ericsson, A. C. Microbiota and reproducibility of rodent models. Lab Anim. 46, 114–122 (2017).
Aranda, C. M. A., Alpuche Aranda, C. M. & Mazzotti, L. R. Antimicrobial Resistance in Developing Countries 491–504 (Springer, 2010).
Ayukekbong, J. A., Ntemgwa, M. & Atabe, A. N. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob. Resist. Infect. Control 6, 47 (2017).
pubmed: 28515903 pmcid: 5433038 doi: 10.1186/s13756-017-0208-x
Cassini, A. et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis. Lancet Infect. Dis. 19, 56–66 (2019).
pubmed: 30409683 pmcid: 6300481 doi: 10.1016/S1473-3099(18)30605-4
O’Neill, J. Antimicrobial resistance: Tackling a crisis for the health and wealth of nations. Rev. Antimicrob. Resist. (London), Grande-Bretagne. https://books.google.lu/books?id=b1EOkAEACAAJ (2014) [Accessed December 2020].
MacLean, R. C. & San Millan, A. The evolution of antibiotic resistance. Science 365, 1082–1083 (2019).
pubmed: 31515374 doi: 10.1126/science.aax3879
Sommer, M. O. A., Dantas, G. & Church, G. M. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 325, 1128–1131 (2009).
pubmed: 19713526 pmcid: 4720503 doi: 10.1126/science.1176950
Baker, S., Thomson, N., Weill, F.-X. & Holt, K. E. Genomic insights into the emergence and spread of antimicrobial-resistant bacterial pathogens. Science 360, 733–738 (2018).
pubmed: 29773743 pmcid: 6510332 doi: 10.1126/science.aar3777
Chen, J. et al. Genome hypermobility by lateral transduction. Science 362, 207–212 (2018).
pubmed: 30309949 doi: 10.1126/science.aat5867
Park, H., Yeo, S., Arellano, K., Kim, H. R. & Holzapfel, W. Role of the gut microbiota in health and disease. In Probiotics and Prebiotics in Animal Health and Food Safety. (eds Di Gioia, D. & Biavati, B.) (Springer, Cham, 2018).
Kennedy, E. A., King, K. Y. & Baldridge, M. T. Mouse microbiota models: Comparing germ-free mice and antibiotics treatment as tools for modifying gut bacteria. Front. Physiol. 9, 1534 (2018).
pubmed: 30429801 pmcid: 6220354 doi: 10.3389/fphys.2018.01534
de Nies, L. et al. PathoFact: A pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic data. Microbiome 9, 49 (2021).
pubmed: 33597026 pmcid: 7890817 doi: 10.1186/s40168-020-00993-9
Johnson, T. A. et al. Clusters of antibiotic resistance genes enriched together stay together in swine agriculture. MBio 7, e02214–e02215 (2016).
pubmed: 27073098 pmcid: 4959523 doi: 10.1128/mBio.02214-15
Chaumeil, P.-A., Mussig, A. J., Hugenholtz, P. & Parks, D. H. GTDB-Tk: A toolkit to classify genomes with the Genome Taxonomy Database. Bioinformatics 36, 1925–1927 (2019).
pmcid: 7703759
Song, W., Wemheuer, B., Zhang, S., Steensen, K. & Thomas, T. MetaCHIP: Community-level horizontal gene transfer identification through the combination of best-match and phylogenetic approaches. Microbiome 7, 36 (2019).
pubmed: 30832740 pmcid: 6399960 doi: 10.1186/s40168-019-0649-y
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8
Dosani, S. Penicillin Man: Alexander Fleming and the antibiotic revolution. BMJ 330, 50 (2004).
Howell, J. D., Macfarlane, G. & Sheehan, J. C. Alexander Fleming: The man and the myth. Technol. Cult. 27, 309 (1986).
doi: 10.2307/3105159
Organization, W. H. & Others. WHO global strategy for containment of antimicrobial resistance. https://apps.who.int/iris/bitstream/handle/10665/66860/WHO_CDS_CSR_DRS_2001.2.pdf (2001).
Culp, E. J. et al. Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling. Nature 578, 582–587 (2020).
pubmed: 32051588 doi: 10.1038/s41586-020-1990-9
Leekha, S., Terrell, C. L. & Edson, R. S. General principles of antimicrobial therapy. Mayo Clin. Proc. 86, 156–167 (2011).
pubmed: 21282489 pmcid: 3031442 doi: 10.4065/mcp.2010.0639
Lamb, R. et al. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease. Oncotarget 6, 4569 (2015).
pubmed: 25625193 pmcid: 4467100 doi: 10.18632/oncotarget.3174
Wilcox, M. H. et al. MODIFY I and MODIFY II Investigators. Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N. Engl. J. Med. 376, 305–317 (2017).
pubmed: 28121498 doi: 10.1056/NEJMoa1602615
Allen, J., David, M. & Veerman, J. L. Systematic review of the cost-effectiveness of preoperative antibiotic prophylaxis in reducing surgical-site infection. BJS Open 2, 81–98 (2018).
pubmed: 29951632 pmcid: 5989978 doi: 10.1002/bjs5.45
Crader, M. F. & Varacallo, M. Preoperative Antibiotic Prophylaxis (StatPearls Publishing, 2020).
Deresinski, S. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections. Clin. Infect. Dis. 49, 1072–1079 (2009).
pubmed: 19725789 doi: 10.1086/605572
Rodrigues, R. R. et al. Antibiotic-induced alterations in gut microbiota are associated with changes in glucose metabolism in healthy mice. Front. Microbiol. 8, 2306 (2017).
pubmed: 29213261 pmcid: 5702803 doi: 10.3389/fmicb.2017.02306
Croswell, A., Amir, E., Teggatz, P., Barman, M. & Salzman, N. H. Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection. Infect. Immun. 77, 2741–2753 (2009).
pubmed: 19380465 pmcid: 2708550 doi: 10.1128/IAI.00006-09
Bratzler, D. W. et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg. Infect. 14, 73–156 (2013).
doi: 10.1089/sur.2013.9999
Hansen, C. H. F. et al. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia 55, 2285–2294 (2012).
pubmed: 22572803 doi: 10.1007/s00125-012-2564-7
Ray, P., Pandey, U. & Aich, P. Comparative analysis of beneficial effects of vancomycin treatment on Th1- and Th2-biased mice and the role of gut microbiota. J. Appl. Microbiol. https://doi.org/10.1111/jam.14853 (2020).
Basolo, A. et al. Effects of underfeeding and oral vancomycin on gut microbiome and nutrient absorption in humans. Nat. Med. 26, 589–598 (2020).
pubmed: 32235930 doi: 10.1038/s41591-020-0801-z
van Passel, M. W. J. et al. The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS One 6, e16876 (2011).
pubmed: 21390229 pmcid: 3048395 doi: 10.1371/journal.pone.0016876
Palleja, A. et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat. Microbiol. 3, 1255–1265 (2018).
pubmed: 30349083 doi: 10.1038/s41564-018-0257-9
Guo, X. et al. Genome sequencing of 39 Akkermansia muciniphila isolates reveals its population structure, genomic and functional diverisity, and global distribution in mammalian gut microbiotas. BMC Genomics 18, 800 (2017).
pubmed: 29047329 pmcid: 5648452 doi: 10.1186/s12864-017-4195-3
Madsen, J. S., Sørensen, S. J. & Burmølle, M. Bacterial social interactions and the emergence of community-intrinsic properties. Curr. Opin. Microbiol. 42, 104–109 (2018).
pubmed: 29197823 doi: 10.1016/j.mib.2017.11.018
Camilli, A. & Bassler, B. L. Bacterial small-molecule signaling pathways. Science 311, 1113–1116 (2006).
pubmed: 16497924 pmcid: 2776824 doi: 10.1126/science.1121357
Meredith, H. R., Srimani, J. K., Lee, A. J., Lopatkin, A. J. & You, L. Collective antibiotic tolerance: mechanisms, dynamics, and intervention. Nat. Chem. Biol. 11, 182–188 (2015).
pubmed: 25689336 pmcid: 4806783 doi: 10.1038/nchembio.1754
Hibbing, M. E., Fuqua, C., Parsek, M. R. & Peterson, S. B. Bacterial competition: Surviving and thriving in the microbial jungle. Nat. Rev. Microbiol. 8, 15–25 (2010).
pubmed: 19946288 pmcid: 2879262 doi: 10.1038/nrmicro2259
Xu, L. et al. The effect of antibiotics on the gut microbiome: A metagenomics analysis of microbial shift and gut antibiotic resistance in antibiotic treated mice. BMC Genomics 21, 263 (2020).
pubmed: 32228448 pmcid: 7106814 doi: 10.1186/s12864-020-6665-2
Gillings, M. R. Integrons: Past, present, and future. Microbiol. Mol. Biol. Rev. 78, 257–277 (2014).
pubmed: 24847022 pmcid: 4054258 doi: 10.1128/MMBR.00056-13
Raymond, F. et al. The initial state of the human gut microbiome determines its reshaping by antibiotics. ISME J. 10, 707–720 (2016).
pubmed: 26359913 doi: 10.1038/ismej.2015.148
Ericsson, A. C., Akter, S., Hanson, M. M. & Busi, S. B. Differential susceptibility to colorectal cancer due to naturally occurring gut microbiota. Oncotarget 6, 33689–704 (2015).
Wampach, L. et al. Birth mode is associated with earliest strain-conferred gut microbiome functions and immunostimulatory potential. Nat. Commun. 9, 5091 (2018).
pubmed: 30504906 pmcid: 6269548 doi: 10.1038/s41467-018-07631-x
Narayanasamy, S. et al. IMP: A pipeline for reproducible reference-independent integrated metagenomic and metatranscriptomic analyses. Genome Biol. 17, 260 (2016).
pubmed: 27986083 pmcid: 5159968 doi: 10.1186/s13059-016-1116-8
Heintz-Buschart, A. et al. Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes. Nat. Microbiol. 2, 16180 (2016).
pubmed: 27723761 doi: 10.1038/nmicrobiol.2016.180
Li, D., Liu, C.-M., Luo, R., Sadakane, K. & Lam, T.-W. MEGAHIT: An ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph. Bioinformatics 31, 1674–1676 (2015).
pubmed: 25609793 doi: 10.1093/bioinformatics/btv033
Milanese, A. et al. Microbial abundance, activity and population genomic profiling with mOTUs2. Nat. Commun. 10, 1–11 (2019).
doi: 10.1038/s41467-019-08844-4
Kang, D. D. et al. MetaBAT 2: An adaptive binning algorithm for robust and efficient genome reconstruction from metagenome assemblies. PeerJ 7, e7359 (2019).
pubmed: 31388474 pmcid: 6662567 doi: 10.7717/peerj.7359
Wu, Y.-W., Simmons, B. A. & Singer, S. W. MaxBin 2.0: An automated binning algorithm to recover genomes from multiple metagenomic datasets. Bioinformatics 32, 605–607 (2016).
pubmed: 26515820 doi: 10.1093/bioinformatics/btv638
Sieber, C. M. K. et al. Recovery of genomes from metagenomes via a dereplication, aggregation, and scoring strategy. Nat. Microbiol. 3, 836–843 (2018).
pubmed: 29807988 pmcid: 6786971 doi: 10.1038/s41564-018-0171-1
Parks, D. H., Imelfort, M., Skennerton, C. T., Hugenholtz, P. & Tyson, G. W. CheckM: Assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes. Genome Res 25, 1043–1055 (2015).
pubmed: 25977477 pmcid: 4484387 doi: 10.1101/gr.186072.114
Eren, A. M. et al. Anvi’o: An advanced analysis and visualization platform for ‘omics data. PeerJ 3, e1319 (2015).
pubmed: 26500826 pmcid: 4614810 doi: 10.7717/peerj.1319
Prjibelski, A., Antipov, D., Meleshko, D., Lapidus, A. & Korobeynikov, A. Using SPAdes De Novo Assembler. Curr. Protoc. Bioinform. 70, e102 (2020).
doi: 10.1002/cpbi.102
Alcock, B. P. et al. CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res. 48, D517–D525 (2020).
pubmed: 31665441
Hu, Y. et al. Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat. Commun. 4, 2151 (2013).
pubmed: 23877117 doi: 10.1038/ncomms3151
Pereira, M. B., Wallroth, M., Kristiansson, E. & Axelson-Fisk, M. HattCI: Fast and accurate attC site identification using hidden Markov models. J. Comput. Biol. 23, 891–902 (2016).
pubmed: 27428829 doi: 10.1089/cmb.2016.0024
UniProt Consortium. UniProt: A worldwide hub of protein knowledge. Nucleic Acids Res. 47, D506–D515 (2019).
doi: 10.1093/nar/gky1049
Prism, G. Graphpad software. San Diego, CA, USA (1994).

Auteurs

Laura de Nies (L)

Systems Ecology Group, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.

Susheel Bhanu Busi (SB)

Systems Ecology Group, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.

Mina Tsenkova (M)

Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.

Rashi Halder (R)

Systems Ecology Group, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.

Elisabeth Letellier (E)

Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg. paul.wilmes@uni.lu.

Paul Wilmes (P)

Systems Ecology Group, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg. elisabeth.letellier@uni.lu.
Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg. elisabeth.letellier@uni.lu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH